公开(公告)号：US4925591A

公开(公告)日：1990-05-15

申请号：US288379

申请日：1988-12-22

申请人： Jun Nakauchi ,  Mioko Uematsu ,  Keiichi Sakashita ,  Yoshitaka Kageyama ,  Seiji Hayashi ,  Kenji Mori

发明人： Jun Nakauchi ,  Mioko Uematsu ,  Keiichi Sakashita ,  Yoshitaka Kageyama ,  Seiji Hayashi ,  Kenji Mori

IPC分类号： C07C69/773 ,  C09K19/12 ,  C09K19/20

CPC分类号： C09K19/126 ,  C09K19/20 ,  C09K19/2021

摘要： Disclosed is a mesomorphic compound having a .beta.-hydroxycarboxyl group as the chiral source, which is represented by the formula: ##STR1## wherein m and n are integers of from 1 to 18, X.sub.1 and X.sub.2 independently represent fluorine, chlorine or hydrogen, Y represents ##STR2## or --O--, Z represents a direct bond, ##STR3## --CH hd 2O-- or --OCH.sub.2 --, and * indicates the asymmetric carbon. The mesomorphic compound is valuable as a ferroelectric liquid crystal or an additive to a ferroelectric liquid crystal or to a compound showing the SmC phase and having no chiral group.

公开(公告)号：US5045228A

公开(公告)日：1991-09-03

申请号：US463814

申请日：1990-01-16

申请人： Jun Nakauchi ,  Mioko Uematsu ,  Keiichi Sakashita ,  Yoshitaka Kageyama ,  Kenji Mori

发明人： Jun Nakauchi ,  Mioko Uematsu ,  Keiichi Sakashita ,  Yoshitaka Kageyama ,  Kenji Mori

IPC分类号： C07D309/30 ,  C07D405/12 ,  C09K19/34

CPC分类号： C07D405/12 ,  C07D309/30 ,  C09K19/3402 ,  C09K19/3463 ,  C09K2019/3422

摘要： An optically active compound having a .delta.-valerolactone ring which is a ferroelectric liquid crystal and is represented by the following general formula (I): ##STR1## wherein m is an integer of from 1 to 8, Z is a group represented by the following formula: ##STR2## in which each of l and k is a number of 1 or 2 and l and k satisfy the requirement of 2.ltoreq.(l+k).ltoreq.3,X stands for a direct bond, ##STR3## Y stands for ##STR4## and A.sub.1 and A.sub.2 independently stand for --H, --F or --Cl, ##STR5## R stands for ##STR6## in which n is an integer of from 1 to 18, and * indicates the asymmetric carbon atom.

公开(公告)号：US5164113A

公开(公告)日：1992-11-17

申请号：US515754

申请日：1990-04-30

申请人： Tetsuya Ikemoto ,  Keiichi Sakashita ,  Seiji Hayashi ,  Yoshitaka Kageyama ,  Yoshihiro Sako ,  Kenji Mori ,  Jun Nakauchi

发明人： Tetsuya Ikemoto ,  Keiichi Sakashita ,  Seiji Hayashi ,  Yoshitaka Kageyama ,  Yoshihiro Sako ,  Kenji Mori ,  Jun Nakauchi

IPC分类号： C07D309/30 ,  C07D405/12 ,  C09K19/34 ,  C09K19/58

CPC分类号： C07D405/12 ,  C07D309/30 ,  C09K19/3402 ,  C09K19/3441 ,  C09K19/588 ,  C09K2019/3422

摘要： An optically active compound represented by the formula: ##STR1##

公开(公告)号：US08551959B2

公开(公告)日：2013-10-08

申请号：US12934515

申请日：2009-03-25

申请人： Takuya Tashiro ,  Kenji Mori ,  Masao Shiozaki ,  Ryusuke Nakagawa ,  Masaru Taniguchi ,  Hiroshi Watarai

发明人： Takuya Tashiro ,  Kenji Mori ,  Masao Shiozaki ,  Ryusuke Nakagawa ,  Masaru Taniguchi ,  Hiroshi Watarai

IPC分类号： A01N43/04 ,  A61K31/70 ,  A61K39/00 ,  C07H15/00 ,  C07H19/00

CPC分类号： C07H15/04

摘要： The invention provides a glycolipid effective for cancer treatment and the like and a synthetic intermediate therefor, as well as a medicament containing the glycolipid and the like. The glycolipid is represented by the formula (1) or a salt thereof

摘要翻译： 本发明提供了对癌症治疗等有效的糖脂及其合成中间体，以及含有糖脂等的药物。 糖脂由式（1）表示或其盐

公开(公告)号：US20130005669A1

公开(公告)日：2013-01-03

申请号：US13577159

申请日：2011-02-04

申请人： Takuya Tashiro ,  Kenji Mori ,  Masao Shiozaki ,  Masaru Taniguchi ,  Hiroshi Watarai

发明人： Takuya Tashiro ,  Kenji Mori ,  Masao Shiozaki ,  Masaru Taniguchi ,  Hiroshi Watarai

IPC分类号： A61K31/7028 ,  A61P35/00 ,  C07H15/203 ,  A61P31/00 ,  C07H1/00 ,  C07H15/04 ,  C12N5/0783

CPC分类号： C07H15/04 ,  A61K31/7032

摘要： A compound represented by the following formula (1): wherein R1 is an aldopyranose residue wherein the 6-hydroxyl group is optionally alkylated, R2 is a C1-26 hydrocarbon group optionally having substituent(s), R3 is a hydrogen atom or a C1-26 hydrocarbon group optionally having substituent(s), R4 is a C1-21 hydrocarbon group optionally having substituent(s), X is an oxygen atom or —CH2—, and Y is —CH2—, —CH(OH)— or —CH═CH—, or a salt thereof is useful for the prophylaxis or treatment of cancer or infection, since it can preferentially induce production of IFN-γ of NKT cells.

摘要翻译： 由下式（1）表示的化合物：其中R1是吡喃葡萄糖残基，其中6-羟基任选被烷基化，R 2是任选具有取代基的C 1-26烃基，R 3是氢原子或C 1 -26任选具有取代基的烃基，R4是任选具有取代基的C 1-12烃基，X是氧原子或-CH 2 - ，Y是-CH 2 - ， - CH（OH） - 或 -CH = CH-或其盐可用于预防或治疗癌症或感染，因为其可优先诱导NKT细胞的IFN-γ的产生。

公开(公告)号：US07973753B2

公开(公告)日：2011-07-05

申请号：US11866028

申请日：2007-10-02

申请人： Kenji Mori

发明人： Kenji Mori

IPC分类号： G09G3/36

CPC分类号： G09G5/003 ,  G09G3/3406 ,  G09G5/02 ,  G09G2320/0242 ,  G09G2320/0626 ,  G09G2320/066 ,  G09G2320/0673 ,  G09G2330/021 ,  G09G2360/16 ,  G09G2360/18

摘要： An image display device corrects image data, which are used for displaying an image, using a gray scale value assigned to each pixel and also controls the amount of source light emitted from a light source. The image display device includes a source light amount control device and an image correction device. The source light amount control device determines the amount of source light and then controls the amount of source light. The image correction device corrects a signal used for changing saturations of the image data so as to reduce a change in the saturations due to a change in the amount of source light, the change in the amount of source light being performed by the light source amount control device.

摘要翻译： 图像显示装置使用分配给每个像素的灰度值来校正用于显示图像的图像数据，并且还控制从光源发射的光源的量。 图像显示装置包括源光量控制装置和图像校正装置。 源光量控制装置确定源光量，然后控制源光量。 图像校正装置校正用于改变图像数据的饱和度的信号，以减少由于光源量的变化引起的饱和度的变化，源光的量的变化由光源量 控制装置

公开(公告)号：US07888988B2

公开(公告)日：2011-02-15

申请号：US12185837

申请日：2008-08-05

申请人： Kenji Mori ,  Masayuki Takori

发明人： Kenji Mori ,  Masayuki Takori

IPC分类号： G11C17/16 ,  H03K17/18

CPC分类号： G11C17/16 ,  G11C17/18

摘要： A fuse circuit includes a first power supply line, a second power supply line, a first current source connected between the first power supply line and an output terminal, a second current source connected between the second power supply line and the output terminal, the second current source having higher current supply capacity or current draw-out capacity than the first current source, and a fuse connected in series with the second current source between the second power supply line and the output terminal.

摘要翻译： 熔丝电路包括第一电源线，第二电源线，连接在第一电源线和输出端之间的第一电流源，连接在第二电源线和输出端之间的第二电流源，第二电源 电流源具有比第一电流源更高的电流供应能力或电流抽出能力，以及在第二电源线和输出端之间与第二电流源串联连接的熔丝。

公开(公告)号：US20100324469A1

公开(公告)日：2010-12-23

申请号：US12681508

申请日：2008-10-03

申请人： Kenji Mori ,  Takamitsu Miyagi ,  Yayoi Shimada ,  Kuei-Chen Chiang ,  Naoya Ohmori ,  Takeshi Goto ,  Shuji Sato

发明人： Kenji Mori ,  Takamitsu Miyagi ,  Yayoi Shimada ,  Kuei-Chen Chiang ,  Naoya Ohmori ,  Takeshi Goto ,  Shuji Sato

IPC分类号： A61N1/30

CPC分类号： A61N1/0448 ,  A61K39/00 ,  A61K2039/53 ,  A61K2039/54 ,  A61N1/0436 ,  A61N1/0444 ,  A61N1/30 ,  A61N1/325

摘要： It is an object of the present invention to provide a method and an apparatus capable of noninvasively administrating vaccine through the skin, and thereby making the immune response activate. A drug product according to the present invention is characterized in that the drug product has a support medium, an electrode formed on the support medium and protected partly by an insulating material for avoiding a direct cutaneous contact, a vaccine containing layer for containing a vaccine, wherein the vaccine is an antigen for inducing an immune suppression protein. A method of administrating a vaccine according to the present invention is characterized in that the vaccine is administrated by the iontophoresis using the drug product according to the drug product of the present invention as an electrode. An apparatus for the iontophoresis according to the present invention is characterized in that the drug product according to the present invention is used as an electrode.

摘要翻译： 本发明的目的是提供一种能够通过皮肤无刺激地施用疫苗，从而使免疫反应活化的方法和装置。 根据本发明的药物产品的特征在于药物产品具有载体介质，形成在载体介质上的电极，部分地被绝缘材料保护以避免直接皮肤接触，含有疫苗的疫苗含有层， 其中所述疫苗是用于诱导免疫抑制蛋白的抗原。 本发明疫苗的施用方法的特征在于，使用本发明药物的药物作为电极，通过离子电渗法给予疫苗。 本发明的离子电渗疗法的特征在于，将本发明的药物用作电极。

公开(公告)号：US20090055049A1

公开(公告)日：2009-02-26

申请号：US11815133

申请日：2006-02-10

申请人： Toru Sakaguchi ,  Kenji Mori

发明人： Toru Sakaguchi ,  Kenji Mori

IPC分类号： B62D6/00

CPC分类号： B62D5/0463

摘要： In a control apparatus of an electric power steering apparatus structured such as to control a motor applying a steering assist force to a steering mechanism on the basis of a current command value calculated from a steering assist command value calculated on the basis of a steering torque generated in a steering shaft and a current value of the motor, it is always possible to execute a high-performance control regardless of a steering speed, by setting a first differential compensator and a second differential compensator inputting a steering torque, making a sampling cycle of the second differential compensator slower than a sampling cycle of the first differential compensator, and adding outputs of the first differential compensator and the second differential compensator to the steering assist command value.

摘要翻译： 在电动助力转向装置的控制装置中，根据从根据产生的转向转矩计算出的转向辅助指令值计算的电流指令值，控制向转向机构施加转向辅助力的电动机 在转向轴和电动机的电流值中，通过设置第一差动补偿器和输入转向转矩的第二差动补偿器，总是可以执行与转向速度无关的高性能控制，使得取样周期为 所述第二差分补偿器比所述第一差分补偿器的采样周期慢，并且将所述第一差分补偿器和所述第二差分补偿器的输出相加于所述转向辅助指令值。

公开(公告)号：US07454656B2

公开(公告)日：2008-11-18

申请号：US10937311

申请日：2004-09-10

申请人： Naoki Okada ,  Kenji Mori ,  Nobuyuki Minowa

发明人： Naoki Okada ,  Kenji Mori ,  Nobuyuki Minowa

IPC分类号： G06F11/00

CPC分类号： G06F11/1441

摘要： According to the present invention, in cases where a CHA function and a DKA function are mounted within a single package, a battery power supply that is used during the occurrence of power supply trouble is effectively utilized so that the supply of power can be separately controlled for each function. A CHA part and DKA part are disposed in a single control package. When trouble such as a power outage is detected, the CHA part blocks access requests from the host, and initiates end processing. When the end processing of the CHA part is completed, the package internal power supply control part stops the clock supply to the CHA part. Then, when the DKA part completes destage processing, the package internal power supply control part stops the supply of power to the DKA part. The power consumption of the package is lowered in stages in accordance with the progress of the end processing.

摘要翻译： 根据本发明，在单个封装中安装有CHA功能和DKA功能的情况下，有效地利用在发生电源故障期间使用的电池电源，从而可以单独控制电力供应 对于每个功能 CHA部件和DKA部件设置在单个控制包装中。 当检测到停电等故障时，CHA部分阻止来自主机的访问请求，并开始结束处理。 当CHA部件的结束处理完成时，封装内部电源控制部分停止对CHA部件的时钟供给。 然后，当DKA部件完成停止处理时，封装内部电源控制部分停止向DKA部件供电。 根据最终处理的进度，包装的功耗逐级降低。